Abstract. Several authors have proved Lefschetz type formulae for the local Euler obstruction. In particular, a result of this type is proved in [BLS]. The formula proved in that paper turns out to be equivalent to saying that the local Euler obstruction, as a constructible function, satisfies the local Euler condition (in bivariant theory) with respect to general linear forms. The purpose of this work is to understand what prevents the local Euler obstruction of satisfying the local Euler condition with respect to functions which are singular at the considered point. This is measured by an invariant (or "defect") of such functions that we define below. We give an interpretation of this defect in terms of vanishing cycles, which allows us to calculate it algebraically, using [Ma2,Ma3]. When the function has an isolated singularity, our invariant can be defined geometrically, via obstruction theory. We notice that this invariant unifies the usual concepts of the Milnor number of a function and of the local Euler obstruction of an analytic set.
INTRODUCTION.This work is a natural continuation of [BLS], where it is proved a Lefschetztype formula for the local Euler obstruction. More precisely, let (X, 0) be an equidimensional complex analytic singularity germ in an open set U ⊂ C N . We endow (X, 0) with a Whitney stratification {V i } and consider a general complex linear form l : C N → C. The formula of [BLS] says that the local Euler obstruction of X at 0 satisfies:where B ε is a small ball around 0 in C N , t 0 ∈ C \ {0} is sufficiently near {0} and Eu X (V i ) is the Euler obstruction of X at any point of the stratum V i .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.